在肺癌中探索治疗途径:表观遗传学的视角
Raluca Munteanu1,2, Ciprian Tomuleasa1,3,4, Cristina-Adela Iuga5,6
1Medfuture Research Center for Advanced Medicine, Iuliu Hatieganu University of Medicine and Pharmacy, 400347 Cluj-Napoca, Romania.
Cancers
|November 25, 2023
概括
本综述探讨了肺癌的新型表观遗传疗法,重点关注甲基化调制以克服治疗耐药性并改善非小细胞肺癌 (NSCLC) 和小细胞肺癌 (SCLC) 的结果.
科学领域:
- 在瘤学瘤学.
- 表观遗传学 在表观遗传学中,表观遗传学是指表观遗传学.
- 分子生物学分子生物学
背景情况:
- 肺癌,包括非小细胞肺癌 (NSCLC) 和小细胞肺癌 (SCLC),死亡率很高.
- 目前的治疗方法,如化疗和放射治疗,由于获得的耐药性和副作用,往往面临有限的疗效.
研究的目的:
- 为肺癌治疗策略提供一个新的视角.
- 在肺癌治疗中强调针对表观遗传变化的干预措施,特别是甲基化模式.
主要方法:
- 审查最近在甲基化模式的表观遗传调制方面的进展.
- 分析过去和当前的临床试验,涉及针对甲基化的分子剂.
- 评估甲基化修饰药物作为单一疗法和组合疗法.
主要成果:
- 识别用于甲基化模式调节的新兴分子剂.
- 对临床试验数据的评估 关于表观遗传疗法在肺癌中的疗效.
- 分析与甲基化修饰药物相关的挑战和优势.
结论:
- 表观遗传干预,特别是甲基化调制,为肺癌治疗提供了一个有希望的新途径.
- 需要进一步的研究和临床试验,以充分阐明这些药物在NSCLC和SCLC的联合治疗中的潜力.
相关概念视频
Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
Epigenetic Regulation
3.0K
Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
X-chromosome...
3.0K
Cancer Therapies
7.7K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.7K


